MDXGMIMEDX GROUP, INC.vs its industry peers
A metric-by-metric comparison of MIMEDX GROUP, INC. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDXGThis | $688M#3 | 118.0x#3 | 3.2x#3 | 1.6x#2 | 20.0%#3 | 14.5%#4 | 15.3%#2 | 22.5%#1 | 48.1%#1 | 8#1 | -32.2%#5 | — |
| IRMD | $1.1B#1 | 46.1x#2 | 10.4x#6 | 12.6x#6 | 14.4%#5 | 16.9%#3 | 31.2%#1 | 22.1%#2 | — | — | 16.9%#4 | 1.4%#1 |
| SIBN | $831M#2 | — | 4.6x#4 | 4.1x#4 | 20.2%#2 | 38.8%#2 | -11.1%#5 | -10.4%#5 | -12.0%#3 | 6#4 | — | — |
| KIDS | $604M#4 | — | 1.8x#1 | 2.6x#3 | 15.4%#4 | -4.8%#6 | -16.6%#6 | -11.5%#6 | -8.6%#2 | 3#5 | 18.4%#3 | — |
| DCTH | $562M#5 | 810.5x#4 | 4.6x#5 | 6.6x#5 | 129.1%#1 | 110.2%#1 | 0.8%#4 | 2.2%#4 | — | 8#1 | 46.9%#2 | — |
| TCMD | $502M#6 | 20.7x#1 | 2.2x#2 | 1.5x#1 | 12.5%#6 | 12.5%#5 | 8.9%#3 | 8.5%#3 | — | 8#1 | 60.5%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice